
IBD Drive Time: Upadacitinib Therapy for Crohn’s Disease
Gastroenterology Learning Network
00:00
Introduction
Discussion of the development and efficacy of Upadacitinib (UPA) therapy for Crohn's disease, including the phase two Celeste trial and pivotal trial results.
Transcript
Play full episode